A Feasibility Study: Assessing Photobiomodulation in Myalgic Encephalomyelitis

NAEnrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2024

Conditions

Myalgic EncephalomyelitisChronic Fatigue Syndrome

Interventions

OTHER

Photobiomodulation therapy

deep red light therapy (670nm)

Trial Locations (1)

Quadram Institute Bioscience, Norwich

All Listed Sponsors

collaborator

University of East Anglia

OTHER

lead

Quadram Institute Bioscience

OTHER